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ABSTRACT
The purpose of this research was to determine the fate of amoxicillin in the City
of Lubbock’s Water Reclamation Plant and to determine the antibiotic resistance patterns
in the plant.  Amoxicillin was detected in the influent of the plant during one month of
the study, but amoxicillin was not detected at any other plant flow streams.  The
antibiotic resistance patterns of the LWRP varied monthly; heterotrophic bacteria were
resistant to most of the antibiotics investigated during the nine month study.
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1INTRODUCTION
As existing potable water supplies are depleted and populations continue to grow
in arid and semi-arid areas of the country, including West Texas, the need for complete
recycling of wastewater for water distribution may become necessary.  Already the
dilution factor for wastewater effluent continues to decrease with shorter and shorter
intervals between release and reuse.  Many municipalities are in fact using treated
effluent in their primary water source although it may have spent some time in a natural
water course.  Historically, the concern with recycled wastewater has been the presence
of disease-causing organisms called pathogens.  However, a more recent concern of
reusing wastewater for consumption is the presence of chemical contaminants, including
a new category of compounds: personal care products and pharmaceuticals.
Pharmaceuticals, including anti-inflammatories, antibiotics, caffeine, hormones,
antidepressants, and others have been observed in various water bodies (Ternes et al.,
1998; Heberer et al., 1998; Hirsch et al., 1999; Qiting and Xiheng, 1988).
Antibiotics are one especially troubling class of compounds due to the build-up of
resistance in microbial populations.  Antibiotics enter the environment from a variety of
sources including discharges from domestic wastewater treatment plants and
pharmaceutical companies, runoff from animal feeding operations, infiltration from
aquaculture activities, leachate from landfills, and leachate from compost made of animal
manure containing antibiotics (Figure 1).  However, antibiotics are not confined to the
natural aquatic environment.  Detectable concentrations of antibiotics have been observed
in tap water (Herberer et al., 1998; Masters, 2001).  The startling fact is that these
compounds are passing through water treatment processes and contaminating drinking
water supplies.  The concentrations of these contaminants typically range from
nanogram/liter (ng/L) to microgram/liter (mg/L); the consequences of their presence at
these concentrations are unknown.  The overall potential for antibiotic removal by
biological and physiochemical treatment systems and simultaneous risk of antibiotic
resistance development has been relatively unexplored.
2Figure 1.  Sources, pathways, and sinks of pharmaceuticals (Kummerer, 2001).
Research has begun to determine the concentrations of antibiotics in the
environment, and from this information, the health effects to humans and animals may be
estimated by toxicologists.  An additional problem that may be created by the presence of
antibiotics at low concentrations in the environment is the development of antibiotic
resistant bacteria.  In recent years, the incidence of antibiotic resistant bacteria has
increased and many people believe the increase is due to the use of antibiotics (Walter
and Vennes, 1985).  The presence of antibiotics can result in selective pressure that
favors organisms that possess genes coding for antibiotic resistance.  This may pose a
serious threat to public health in that more and more infections may no longer be
treatable with known antibiotics (Hirsch et al., 1999).  In the event that antibiotic
resistance is spread from nonpathogenic to pathogenic bacteria, epidemics may result.  In
fact, bacteria have been observed to transfer their resistance in laboratory settings as well
as the natural environment (Kanay, 1983).
3The objective of this research was to investigate the effect of a representative
pharmaceutical in a biological water reclamation system.  The antibiotic evaluated in this
study was amoxicillin, which is a semi-synthetic, beta-lactam antibiotic used for a variety
of infections. The focus of this particular project is to determine the fate of amoxicillin in
the City of Lubbock’s Wastewater Reclamation Plant and to determine the antibiotic
resistance patterns in the plant.
4BACKGROUND
Pharmaceuticals are used in large quantities in human and veterinary medicine or
as food additives in animal production (Stan and Heberer, 1997).  In animal feeding
operations, antibiotics are often prescribed as a preventative measure to keep the animals
healthy. The abuse of antibiotics has been rampant since Fleming’s discovery of
penicillin.  Antibiotics were prescribed for the treatment of many illnesses and at doses
that may have been inappropriate.  There are many forms of antibiotic misuse and abuse.
For instance, viral illnesses should not be treated with antibiotics.  Also, patients should
be educated on compliance issues and the importance of proper use of the antibiotic.
Misuse, which includes not completing the prescription, can lead to resistance
development (Leiker, 2000a).  Preventative measures that may be taken by a clinician to
reduce antibiotic resistance development include using the most appropriate spectrum
antibiotic for each infection, shortening the duration of antibiotic treatment, knowing
local resistance patterns, and limiting antimicrobial prophylaxis if possible (Leiker,
2000a).
Due to the overuse of antibiotics, bacteria have developed resistances to
antibiotics.  There are three main modes of antibiotic resistance that generally render the
antibiotic ineffective, but not all bacteria use the same resistance mechanisms.  The first
mechanism prevents the antibiotic from binding with and entering the organism, which
has been observed in some P. aeruginosa (Leiker, 2000b); this form of resistance is
related to Multi-Drug Efflux.  Other examples are Steptococcus pnuemoniae and Group A
Streptococci penicillin-resistant mutants that have been isolated in the laboratory due to
immense and common selective pressure; these mutants contain altered penicillin-binding
proteins (Tomasz and Munoz, 1995).  The second type of resistance mechanism is the
production of an enzyme that inactivates the antibiotic.  The classic example of this
resistance mechanism is the production of beta-lactamase enzymes in H. influenze and M.
catarrhalis, which destroys the beta-lactam ring of the beta-lactam antibiotic.  There are
many different enzymes produced by bacteria that are capable of degrading the beta-
lactam ring.  Fortunately for bacteria, this type of resistance may be spread to other
bacteria through a process called “transference”   (Leiker, 2000b).  The last form of
bacterial resistance is the change in the internal binding site of the antibiotic.  For
5example, the site to which the antibiotic binds has been altered so that the antibiotic may
no longer bind, which makes the bacteria are resistant to the antibiotic.  This process has
been observed in penicillin-resistant S. pneumoniae.
Antibiotic resistance may spread using various mechanisms, including
conjugation, transduction, and transformation.  In conjugation, DNA may be transferred
from one bacterial cell to another in the form of a plasmid.  Plasmids may carry genetic
information in addition to the information contained on a chromosome, which bacteria
may use under special conditions.  For instance, plasmids may carry the genetic
information for antibiotic resistance, virulence, bacteriocins, and metabolic activity
(Madigan et al., 2000).  Transduction is the process in which a part of a donor
chromosome is packaged into a phage head and transferred by viruses.  If the virus
packaging mechanism selects genes that confer antibiotic resistance, then resistance may
be spread to bacterial cells infected by the viruses.  Transformation is the process in
which cells take up free DNA from the environment (Snyder and Champness, 1997).  If
the DNA contains antibiotic resistance genes, then antibiotic resistance may be conferred
to the transformant.  Thus the transformant now has the genetic material encoding
antibiotic resistance.
Amoxicillin
Amoxicillin is an orally absorbed broad-spectrum antibiotic with a variety of
clinical uses including ear, nose, and throat infections and lower respiratory tract
infections.  As a chemical modification of ampicillin, which is poorly absorbed after oral
administration, amoxicillin is better absorbed by the gastrointestinal tract than ampicillin
(Sum et al., 1989).  Amoxicillin is prescribed for the treatment of infections of beta-
lactamase-negative stains, which are bacterial strains that do not possess the ability to
produce beta-lactamase enzymes.   Figure 2 presents the chemical structures of
amoxicillin (R=0H) and penicilloic acid, a transformation product produced during beta-
lactam ring cleavage.
6Figure 2.  Chemical structure of amoxicillin (left) and penicilloic acid (right)
(Connor et al., 1994).
Amoxicillin is a semi-synthetic penicillin obtaining its antimicrobial properties
from the presence of a beta-lactam ring.  Amoxicillin and other penicillin-like antibiotics
target bacterial cell walls.  Beta-lactam antibiotics bind to and inhibit the enzymes needed
for the synthesis of peptidoglycan, a component of bacterial cell walls.  As bacteria
multiply and divide, the defective walls cannot protect the organism from bursting in
hypotonic environments and cell death occurs.
Many mechanisms exist for resistance to beta-lactam antibiotics.  Resistance is
considered an increase in the minimal inhibitory concentration (MIC) of the antibiotic,
which could be the result of many different mechanisms, whereas tolerance does not alter
the bacteria's susceptibility to the drug but improves bacterial survival during treatment.
For optimal bactericidal action, the dose must be greater than the organism's MIC.  In the
case of beta-lactam antibiotics, this dose is approximately four to five times the MIC.
When antibiotic concentration is less then the MIC, bacteria recover from the exposure
and begin growth (Ronchera, 2001).  When the drug is prescribed to a patient with the
infection, the dose will be greater than the MIC.  However, it is unlikely that wastewater
containing urine and feces will have antibiotic concentrations greater than the MIC;
therefore, antimicrobial effects will probably not be observed.  However, low
concentrations of antibiotics encourage the development of antibiotic resistance.  Thus,
wastewater streams containing urine and feces likely aid in the development of antibiotic
resistance.  In S. aureus, which is a major human pathogen, three mechanisms of beta-
7lactam resistance have been identified: (1) beta-lactamase-mediation inactivated through
hydrolysis of the beta-lactam nucleus, (2) penicillin-binding proteins (PBP)-associate
intrinsic resistance due to the lower of the affinity of PBPs or the acquisition of new
PBPs, and (3) tolerance of the beta-lactam antibiotic as a result of autolysins inhibition
(Georgepapadakou et al.,1988).  PBPs are the enzymatic targets of beta-lactam
antibiotics.  Beta-lactam resistance due to the alteration of PBPs has been detected in
many isolates as well as most of the major human invasive pathogens (Tomasz, 1988).
For Gram-negative organisms, such as E. coli and nitrifying organisms, another
mechanism of resistance to beta-lactam antibiotics, including amoxicillin, is the hindering
of diffusion of the antibiotic by the outer membrane, which acts as a permeability barrier
(Frere and Joris, 1988).  Antibiotics must pass through porins, which are non specific
outer membrane channels.  The antibiotics ability to pass through porins depends on the
size, hydrophobicity, and charge of the antibiotic (Danziger and Pendland, 1995).   In
addition, the outer membrane prevents the leaking of beta-lactamases into the culture
environment (Frere and Joris, 1988).  All bacteria may be divided into Gram-positive and
Gram-negative organisms.  The classification was developed by Gram, which is based on
a dye procedure; the color of the dyed bacteria is related to the composition of bacterial
cell walls.  Gram-positive organisms appear blue following a Gram stain, and they posses
a thick layer of peptidoglycan and no outer membrane.  Beta-lactam antibiotics easily
penetrate the thick layer of peptidoglycan in Gram-positive bacteria (Danziger and
Pendland, 1995).  Gram-negative organisms have an outer membrane and a thin layer of
peptidoglycan inside the periplasmic space and are stained red in a Gram stain.  Figure 3
is a drawing of the cell wall structures of Gram-negative and Gram-positive bacteria.
Figure 3.  Structure of Gram-positive and Gram-negative bacteria (Madigan et al., 2000).
8As mentioned previously, beta-lactamases are enzymes that cleave the beta-
lactam ring and render the antibiotic useless.  The genetic information for beta-
lactamases is contained on either plasmids or chromosomes; however, genes for
resistance are usually carried by plasmids.  Beta-lactamase production may be either
constitutive or inducible.  Constitutive production results in a constant level of beta-
lactamase production, which is independent of exposure to antibiotics.  If beta-lactamase
production is inducible, then beta-lactamases are produced following exposure to a
signal, such as a beta-lactam antibiotic.  Furthermore, production of the beta-lactamases
ceases when the bacterium is no longer exposed to the signal (Danziger and Pendland,
1995).  Beta-lactamases are classified according to (1) their genetic location
(chromosome vs. plasmid), (2) gene expression (inducible vs. constitutive), (3)
microorganism, (4) inhibition by beta-lactamase inhibitors, and (5) substrate.  Figure 4
presents beta-lactamases and their distribution in nature.
Figure 4.  Beta-lactamases and their distribution in nature (Danziger and Pendland,
1995).
9To reduce the potential for beta-lactam cleavage, beta-lactamase inhibitors are
frequently combined with beta-lactam antibiotics.  The purpose of the beta-lactamase
inhibitors is to prevent the beta-lactamases from inactivating the antibiotic thereby
increasing the effectiveness of the antibiotic.  Examples of beta-lactamase inhibitors are
sulbactam, clavulanate, and tazobactam (Danziger and Pendland, 1995).  In many cases,
amoxicillin is combined with clavulanic acid, a beta-lactamase inhibitor.
Antibiotics in the Environment
Drug residues, including antibiotics, have been observed in various aquatic
environments including groundwater, surface water, and tap water (Alvero, 1987;
Campeau et al., 1996).  Sources of antibiotics include the treatment of human infections,
veterinary use (e.g., animal feeding operations), aquaculture, and land application of
compost containing sludge from wastewater treatment plants.  In human uses, which will
be the primary focus of this paper, antibiotics enter waste streams through feces and
urine.  To demonstrate, Hoeverstadt et al. (1986) detected several antibiotics in human
feces, including trimethoprim and doxycycline in concentrations ranging from 3 to 40
mg/kg and erythromycin concentrations from 200 to 300 mg/kg.  The concentration of
antibiotics in urine is dependent on dosage, type of dosing (intravenous, intramuscular, or
oral), food and beverage consumption, and elapsed time since dosage (Mastrandrea et al.,
1984).  In addition, absorption is also a property of the antibiotics.  For example,
amoxicillin is a chemically modified form of ampicillin and the modifications improve its
absorption characteristics.
Extreme difficulties arise in estimating the mass of antibiotics entering the
environment.  In general, records containing the quantity of antibiotics prescribed
annually are incomplete and the data available varies from country to country.
Furthermore, it is unknown if the medication is taken as prescribed.  Absorption rates
vary for each individual further complicating the estimate of antibiotics entering the
environment.  Therefore, researchers have begun analyzing environmental samples for
the presence of antibiotics.  Table 1 presents the concentration of antibiotics present in
secondary effluent and surface water in Germany.
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Table 1.  Concentrations of selected antibiotics applied in Germany (Zwiener et al.,
2001).
Antibiotic
Prescribed Mass
(tons/yr)
Secondary Effluent
Concentration (mg/L)
Surface Water
Concentration (mg/L)
Clarithromycin 1.3-2.6 0.24 0.26
Erythromycin 3.9-19.8 6.00 1.70
Roxithromycin 3.1-6.2 1.00 0.56
Chloramphenicol -- 0.56 0.06
Sulfamethoxazole 16.6-76 2.00 0.48
Trimethoprim 3.3-15 0.66 0.20
In the United States, the U.S. Geological Survey completed a study that measured
the concentrations of 95 organic wastewater contaminants (OWCs) in water samples
from 139 streams in thirty states during 1999 and 2000 (Kolpin et al., 2002).  OWCs
include pharmaceuticals, hormones, and other organic contaminants.  The compounds
detected represented a wide range of residential, industrial, and agricultural sources.  The
most frequently detected compounds were coprostanol (fecal steroid), cholesterol (animal
and plant steroid), insect repellant (N,N-diethyltoluamide), caffeine, triclosan
(antimicrobial disinfectant), fire retardant (tri(2-chloroethyl)phosphate), and a nonionic
detergent metabolite (4-nonylphenol).  In addition to these compounds, 31 veterinary and
human antibiotic and antibiotic metabolites were investigated.  Fourteen of the 31
antibiotics were not detected in this study.  Table 2 contains the antibiotic, frequency of
detection, maximum detected concentration (mg/L), and median detected (mg/L)
concentration of the remaining 17 antibiotics.
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Table 2.  Summary of antibiotics in streams of the U.S. (Kolpin et al., 2002).
Antibiotic
Number of
Samples
Reporting
Level (mg/L)
Frequency
(%)
Max
(mg/L)
Median
(mg/L)
Chlortetracycline (1) 84 0.10 2.4 0.69 0.42
Ciprofloxacin 115 0.02 2.6 0.03 0.02
Erythromycin-H20 104 0.05 21.5 1.7 1.0
Lincomycin 104 0.05 19.2 0.73 0.06
Norfloxacin 115 0.02 0.9 0.12 0.12
Oxytetracycline (2) 84 0.10 1.2 0.34 0.34
Roxithromycin 104 0.03 4.8 0.18 0.05
Sulfadimethozine (2) 84 0.05 1.2 0.06 0.06
Sulfamethazine (1) 104 0.05 4.8 0.12 0.02
Sulfamethazine (2) 84 0.05 1.2 0.22 0.22
Sulfamethizole (1) 104 0.05 1.0 0.13 0.13
Sulfamethoxazole (1) 104 0.05 12.5 1.9 0.15
Sulfamethoxazole (3) 84 0.023 19 0.52 0.066
Tetracycline (2) 84 0.10 1.2 0.11 0.11
Trimethoprim (1) 104 0.03 12.5 0.71 0.15
Trimethoprim (3) 84 0.014 27.4 0.30 0.013
Tylosin (1) 104 0.05 13.5 0.28 0.04
Several studies have identified antibiotics in wastewater treatment plant (WWTP)
flow streams and in WWTP effluents (Stelzer et al., 1985; Grabow et al., 1976; Bell,
1979; Misra et al., 1979; Radtke and Gist, 1989; Malik and Ahmad, 1994) at
concentrations from ng/L to mg/L.  Alder et al. (2000) detected up to 0.8 mg/L of
cirpofloxacin in a WWTP effluent and 0.01 to 0.29 mg/L in the WWTP influent.  Hirsch
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et al. (1999) found erythromycin concentrations up to 6 mg/L in WWTP effluent.
Ciprofloxacin was observed in hospital effluent at concentrations between 3 and 89 mg/L,
which is significantly higher than concentrations presented in other studies.  Amoxicillin
concentrations in wastewater from a German hospital were between 28 and 82.7 mg/L
(Henninger et al., 2000).  Peniciloly groups were observed at concentrations greater than
25 ng/L and 10 mg/L in river water and potable water, respectively (Halling-Sorensen et
al., 1998).  Therefore, wastewater treatment plants (WWTPs) are receiving wastes that
contain low concentrations of antibiotics.  Exposure to small concentrations of antibiotics
selects for organisms resistant to antibiotics.  Subsequently, WWTPs may be a reservoir
of antibiotics as well as antibiotic resistant bacteria.
Antibiotic Resistance
Antibiotic resistance has been observed in various aquatic environments including
river and costal areas, domestic sewage, surface water and sediments, lakes, sewage
polluted ocean water, and drinking water (Merzioui and Baleux, 1994).  These aquatic
environments represent a variety of ecosystems and may include a variety of climates.
The consequences of antibiotic resistant organisms may be different for each
environment.
WWTPs are used to treat domestic and industrial wastewater so that it may be
disposed in the natural aquatic environment, including rivers, lakes and streams, with
minimal impact on aquatic life.  Currently, the WWTP effluent must meet regulatory
limits for suspended solids, nutrients, fecal coliforms, total coliforms, and a biological
oxygen demand; however, regulatory limits have not been developed for antibiotic agents
and the effect of low antibiotic concentrations and antibiotic resistance development
receives limited attention.  The role of WWTPs on the spread of antibiotic resistance to
the natural environment is an important key to the ecological impact of human
discharges.
Antibiotic Resistance in WWTP Influent
WWTPs typically accept discharges from hospitals and may receive discharges
from pharmaceutical plants.  Guardabassi et al. (1998) investigated the antibiotic
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resistance of Acintobacter spp. in sewers receiving waste from a hospital and
pharmaceutical plant.  The level of susceptibility to six antimicrobial agents was
determined in 385 Acinetobacter strains isolated from samples collected upstream and
downstream from the hospital and pharmaceutical plant.  The antimicrobial agents
analyzed include amoxicillin, oxytetracycline, chloramphenicol, sulfamethoxazole,
gentamicin, and ciprofloxacin.  A prevalence of oxytetracycline resistance was observed
to increase in the sewer as the result of hospital discharge; however, the level of
resistance decreased downstream of the discharge.
Antibiotic Resistance in WWTPs and Their Discharges
The incidence of outbreaks involving waterborne antibiotic-resistant bacteria has
led to a serious problem of the death of patients who do not respond to antibiotics.  One
source of antibiotic-resistant bacteria in the environment is effluent from WWTPs
(Hassani et al., 1992).  The purpose of the Hassani et al. (1992) study was to evaluate the
distribution of Aeromonas species present in wastewater treatment ponds to determine the
effect of treatment on drug resistance incurred by the species.  The importance of
evaluating Aeromonas species is that they are a broad group of organisms commonly
found in aquatic environments.  During the course of this 17-month study, the
distribution of the Aeromonas observed in the system differed between the cold and
warm months.  The most common species of Aeromonas observed were A. caviae, A.
hydrophila, and A. sobria.  Seven antibiotics (amoxicillin, cephalothin, streptomycin,
trimethoprim-sulfamethoxazole, chloramphenicol, polymyxin B, and nalidixic acid) were
tested on 264 isolates in this study.  All of the isolates were resistant to amoxicillin and
73 percent exhibited resistance to cephalothin, both of which are beta-lactam antibiotics.
The overall frequency of multiple antibiotic resistances among bacterial isolates was 77
percent and the antibiotic resistance index for the total strains was 0.29.  Temperature
appeared to have an effect on multiple-drug resistance.  During the warm months, the
level of resistance was greater in the bacteria isolated from the influent than those
isolated in the effluent from the pond.  Overall, the A. sobria were more susceptible to the
antibiotics investigated in this study than either A. caviae or A. hydrophila.  In addition,
each species exhibited different resistance patterns than the other species.  For example,
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the resistance to cephalothin of A. caviae, A. hydrophila and A. sobria were 91, 96 and 9
percent, respectively.
Another study evaluated the effect of wastewater stabilization ponds on antibiotic
resistance on Aeromonas (Imzilin et al., 1996).  Differences in resistance patterns of
Aeromonas isolated from the raw sewage and stabilization pond effluent were not
observed.  All strains possessed multiple resistances, including resistance to ampicillin,
amoxicillin, and novobiocin.  Approximately 90 percent of the strains of A. hydrophila
and A. caviae were resistant to cephalothin, and almost 80 percent of the A. sobria were
susceptible.  The results of this study are fairly similar to the results obtained from the
study by Hassani et al. (1992).
Mezriou and Baleux (1994) investigated the antibiotic resistance of 879 E. coli
strains isolated from raw domestic sewage and the effluent from aerobic lagoons and
activated sludge plants.  Both aerobic lagoons and activated sludge plants are used to
reduce the BOD5 leaving the treatment facility.  The results of this study indicate that the
aerobic lagoons were effective in removing fecal coliforms in the wastewater, but the
system selected for antibiotic resistant E. coli by selecting for E. coli.  The number of
antibiotic resistant strains of E. coli in the effluent increased as compared to the influent.
For both the inflow and outflow, the incidence of antibiotic resistance increased as the
number of antibiotics was reduced from seven to one.  The maximum polyresistance for a
strain was seven antibiotics (ampicillin, mezlocillin, gentamicin, netilmicin, tobramycin,
doxycyclin, and chloramphenicol).  The level of antibiotic resistant E. coli strains in the
outflow of the activated sludge was not constant and did not appear to develop in a
manner similar to the aerated lagoon.  In both the activated sludge and aerated lagoon
system, resistance to quinolones and aminosides was not observed.
WWTP Discharges and Their Effect on the Natural Environment
To evaluate the impact of urban effluent, including WWTP discharges, Goni-
Urriza et al. (2000) investigated antibiotic resistance in bacteria isolated from the Arga
River in Spain.  River samples were collected upstream and downstream of the water
discharged from the city of Pamplona’s WWTP.  Enterobacteriaceae, from human and
animal commensal flora, and Aeromonas were investigated.  Most Aeromonas (72
15
percent) and 20 percent of the Enterobacteriaceae were resistant to nalidixic acid, which
is a quinolone.  The rate at which antibiotic resistances decreased downstream from the
discharge was similar for the two groups of bacteria.  Genetic analysis indicated that
these resistances were mostly chromosomal mediated for Enterobacteriaceae and
exclusively chromosomally mediated for Aeromonas.  Other studies have observed less
resistance of native and fecal bacteria upstream of urban areas and WWTP discharges,
increased resistance immediately downstream of urban areas and WWTP discharges, and
decreased resistance farther downstream (Boon and Cattanach, 1999; Pathak et al., 1993;
Iwane et al., 2001).  Another study by Gonzalo et al. (1989) evaluated antibiotic
resistance and virulence factors of 418 E. coli strains isolated from river water receiving
sewage discharge.  The data indicated that bacteria from less contaminated water present
less antibiotic resistance and virulence factors than those isolated from highly
contaminated water.  The results suggest that antibiotic resistance and virulence factors
do not survive well in environments without selective pressure.
Natural aquatic environments, including lakes, rivers, and streams are
environments in which antibiotic resistance may be developed.  Arvanitdou et al. (1997)
investigated the transfer of antibiotic resistance among Salmonella strains isolated from
surface waters in northern Greece.  Differences in antibiotic use and climate conditions
resulted in geographic variations of antibiotic resistance among bacteria in surface water.
The study showed that 24 percent of the Salmonella strains tested showed resistance to
one or more of the antibiotics tested.  Resistance to streptomycin was most common but
was not transferable in all cases.  However, ampicillin resistance (ampicillin is a beta-
lactam antibiotic) was transferable.  The authors believed these findings supported the
presence of a common plasmid-mediated TEM type beta-lactamase.  In one case,
ampicillin resistance was cotransferred with resistance to aminoglycosides.  Bacteria of
non-fecal origin in natural aquatic environments free of natural anthropogenic influence
demonstrated antibiotic resistance to one or more antibiotics; resistance may not be
plasmid-mediated (Magee and Quinn, 1991).
Antibiotic Resistance Transfer
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One of the greatest concerns of antibiotic resistance is the spread of antibiotic
resistance from one bacterial species to another, especially in the case of resistance
transfer between nonpathogenic to pathogenic bacteria.  Antibiotic resistance has been a
concern in an institutionalized environment such as a hospital; however, it may also be a
concern in aquatic environments such as wastewater treatment systems.  Resistance to
newer beta-lactam agents was observed between Klebsiella pneumoniae and E. coli in a
hospital in France, as observed by a decreased susceptibility of E. coli to cefotaxime.
Three beta-lactamases were identified mediating cefotaxime resistance as well as
penicllin and other cephalosporin resistance.  Therefore, these beta-lactamases were
termed extended broad-spectrum beta-lactamases (Jarlier et al., 1988).
Evidence suggests that healthy members of a community may contain a reservoir
of bacterial antibiotic resistance genes even in commensal flora (Shanahan et al., 1994).
These resistance reservoirs may complicate treatment of infections by invading pathogens
who transfer resistance to nonpathogens.  In Gram-negative bacteria, resistance is
commonly mediated by TEM-1 beta-lactamases, which have been shown to account for
up to 80 percent of all plasmid-mediated resistance.  In Edinburgh, U.K., antibiotic
resistance was observed in healthy human subjects, including resistance to ampicillin.
Plasmids containing TEM-1 beta-lactamases encoding information were present
throughout the community and were believed to be culprit of many extended-spectrum
beta-lactamases.
Summary
These studies indicate that industrial and domestic discharges may affect the
antibiotic resistance patterns observed in a WWTP.  Furthermore, WWTPs have the
ability to alter the antibiotic resistance patterns of bacteria in ecosystems containing the
WWTP outfall.  As a consequence, environmental bacteria, pathogens, and non-
pathogens may confer resistance to currently prescribed antibiotics.
Lubbock Water Reclamation Plant
The Lubbock Water Reclamation Plant (LWRP), located in Lubbock, Texas,
served as the test facility for the fate of amoxicillin in a full-scale wastewater treatment
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plant.  The flow rate for the LWRP is approximately 20 MGD.  Figure 5 is a flow
diagram of the LWRP.  Note that there are three process streams for the plant, which
have been the result of plant expansions over the many years of operation.  Primary
treatment of the influent to the plant consists of screening and grit removal.  After
primary treatment, the flow streams are split before secondary treatment.  For secondary
biological treatment, the plant employs activated sludge in Plants 3 and 4.  Plant 2 uses
biotowers for secondary treatment.  The facility does not employ tertiary removal.
Instead, the effluent is used to irrigate farmland, discharged to Yellow House Canyon, or
sent to XCEL.   Sludge from secondary treatment is thickened, digested in anaerobic
digesters, dewatered and landfilled.
The fate of amoxicillin in the LWRP was determined by measuring the ambient
concentrations of amoxicillin at four locations in the plant over nine months.  The
objective of this experiment is to investigate the fate of amoxicillin in a full-scale
wastewater treatment plant.  Due to the dilution of urine by other wastewater streams
entering a full-scale wastewater treatment plant as well as biotic activity in sewer
systems, amoxicillin concentrations were expected to be near the detection limit in the
influent and effluent of the plant, respectively.
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Figure 5.  Schematic of the LWRP.
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EXPERIMENTAL PROCEDURE
Fate of Amoxicillin in a Water Reclamation Plant--Lubbock, TX
Wastewater samples were collected from the influent, primary sludge, activated
sludge basin, and the effluent of the Plant 4 of the LWRP.  Samples were collected by
LWRP personnel on the second Friday of each month from May to December.  Samples
were taken immediately to the ESL and filtered using a 0.45 mm filter.  The primary
sludge samples were centrifuged before filtering.  The wastewater samples were filtered
to prevent clogging of the C18 cartridges, which were required by the amoxicillin
preparation procedure.  All amoxicillin wastewater samples were analyzed in triplicate.
Antibiotic Resistance
The change in antibiotic resistance in the LWRP was investigated at four
locations in the plant over eight months.  To investigate the occurrence of antibiotic
resistance in microorganisms in the systems examined in this research the disk diffusion
susceptibility test was performed on samples obtained from the systems.
To investigate antibiotic resistance of the bacteria used in LWRP, samples were
collected from the influent, activated sludge tank, primary sludge and effluent. Samples
were collected, by LWRP personnel on the second Friday of each month from May to
December in sterile, 1-L bottles.  The samples were immediately taken to the ESL and
analyzed.
The disk diffusion susceptibility test was performed to determine if heterotrophic
organisms in the LWRP samples were resistant to multiple antibiotics.  The LWRP
samples were plated on nutrient agar and Hinton-Mueller plates. The antibiotics
investigated in this study include amoxicillin with clavulanic acid and three other beta
lactam antibiotics: penicillin, ampicillin, and cephalothin.  Other antibiotics investigated
in this study were bacitracin, ciprofloxacin, rifampin, streptomycin, tetracycline, and
vancomycin.  Table 3 lists the antibiotics and their concentrations used in this study.
Table 4 presents a summary of the antibiotics investigated and their mechanisms.
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Table 3.  Antibiotics and concentrations of susceptibility disks.
Antibiotic Concentration (mg)
Amoxicillin with clavulanic acid 30
Ampicillin 10
Bacitracin 10
Penicillin (units) 10
Cephalothin 30
Ciprofloxacin 30
Rifampin 5
Streptomycin 10
Tetracycline 30
Vancomycin 30
To create a lawn of bacteria, 0.1 mL of the wastewater was spread on the agar.
After an incubation period, the zone of inhibition, which is the area around the disk
without bacterial growth, was measured.  The size of the zone of inhibition determined
the susceptibility of the organisms to the antibiotic.  The diameter of the paper disks were
0.7 cm.  If the diameter of the zone of inhibition was between 0.7 and 1.0 cm, the
organisms were considered resistant, because the organisms grew up to the disk.  If the
zone was between 1.0 and 1.2 cm, the bacteria were considered moderately susceptible
and if the zone was greater than 1.2 cm, the microorganisms were considered susceptible.
All samples were conducted in triplicate. Plates were incubated for 24 hours at 30oC.
Media Preparation and Sterilization Procedures
Nutrient agar and Hinton-Mueller agar were used in this experiment.  All of these
products were prepared according to the manufacturer's directions.
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Table 4.  Summary of antibiotics and resistance mechanisms (Kimball, 2001).
Antibiotic Class Mechanism
Amoxicillin Beta-lactam Cell wall synthesis (PBPs)
Ampicillin Beta-lactam Cell wall synthesis (PBPs)
Bacitracin Cell wall synthesis
Cephalothin Beta-lactam Cell wall synthesis (PBPs)
Ciprofloxacin Quinolones DNA gyrase inhibitor
Penicillin Beta-lactam Cell wall synthesis (PBPs)
Rifampin Rifampin Bacterial RNA Polymerase
Streptomycin Aminoglycosides 70s ribosome subunit
Tetracycline Tetracycline 30s ribosome subunit
Vancomycin Glycopeptide Cell wall synthesis (D-alanines)
Sterilization
Liquids, laboratory supplies, and media, when specified, were sterilized using an
autoclave.  The autoclave was operated for 15 minutes at 212oF.  The pressure was
adjusted for Lubbock's elevation.  Glassware was sterilized by dry sterilization, which
requires glassware to be baked in an oven at 180oC for four hours.  Amoxicillin solution
was sterilized by filtering the solution with a 0.22 mm filter.
Amoxicillin Quantification
A method developed by Sorenson and Snor (2001) was used to quantify the
concentration of amoxicillin in the wastewater samples analyzed.  Two milliliters of the
sample was added to 20 mL of phosphate buffer 9.0 and mixed.  Using a vacuum
manifold, SPE cartridges (Waters) were washed with 2.0 mL of methanol and 5 mL of
water.  The samples were drawn through the cartridges at a flow rate of 2.0 mL/min.  The
column was washed three times with 2 mL of phosphate buffer 9.0.  The samples were
vacuumed dried for 1 minute.  The cartridges were eluted with 2.5 mL of acetonitrile,
which was collected in 15 mL polypropylene tubes and evaporated to dryness under
nitrogen at a temperature of 55oC.  The residue was redissolved in 600 mL of phosphate
buffer 9.0 and centrifuged filter through a cellulose membrane filter at 3000 x g for 15
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minutes.  Then, 500 mL of the filtrate was transferred to a 15 mL polypropylene tube.
Next, 75 mL of derivitization reagent I was added and the sample was vortex-mixed for
30 seconds.  After 10 minutes, 450 mL of derivitization reagent II was added and the
sample was vortex-mixed for 60 seconds.  The samples were placed in a water bath
(55oC) to react for 30 minutes.  The samples were cooled in cool water and transferred to
vials.   The samples were quantified using an HPLC.  The injection volume was 500 mL
and the mobile phase flow-rate was 1.0 mL/min.   The detection wavelength was 323 nm.
The analytical instrument was calibrated on each day of analysis, and QC samples were
run at a maximum of 20 samples, followed by blanks, to ensure that the instrument was
still calibrated correctly.
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RESULTS AND DISCUSSION
Fate of Amoxicillin in a Water Reclamation Plant--Lubbock, TX
To investigate the concentration of amoxicillin in a full-scale wastewater
treatment plant, wastewater samples were collected from the Lubbock Wastewater
Reclamation Plant (LWRP) in Lubbock, Texas.  Samples were collected on the second
Friday of every month between May and December 2002.  The samples were
immediately taken to the ESL and analyzed for amoxicillin and antibiotic resistance.  All
samples were analyzed in triplicate.  The purpose of this experiment was to monitor the
fate of amoxicillin in the LWRP to determine if amoxicillin was present in the plant’s
influent and effluent.
During the eight-month experiment, amoxicillin was detected in the influent of
the plant only in the May samples; amoxicillin was not detected at any other sample
locations during any of the months of this study.  Table 5 presents a summary of the
amoxicillin analysis.  NA indicates not applicable.  Due to equipment problems, samples
could not be analyzed in December.
Table 5.  Amoxicillin concentrations in the LWRP.
Amoxicillin Concentration (mg/L)
Month Influent Primary Sludge Activated Sludge Effluent
May 0.15 <0.10 <0.10 <0.10
June <0.10 <0.10 <0.10 <0.10
July <0.10 <0.10 <0.10 <0.10
August <0.10 <0.10 <0.10 <0.10
September <0.10 <0.10 <0.10 <0.10
October <0.10 <0.10 <0.10 <0.10
November <0.10 <0.10 <0.10 <0.10
December NA NA NA NA
During the entire course of the experiment, amoxicillin was not detected in the
effluent of the LWRP.  The results suggested that amoxicillin may not represent an
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environmental concern.  This supported the hypothesis that amoxicillin would not be
present at levels that may exert an impact on reclaimed wastewater end-users or aquatic
life.
Antibiotic Resistance in the LWRP
A summary of the results of the antibiotic resistance tests performed using the
LWRP wastewater are presented in Tables 6 through 9.  Due to the large volume of data
collected, a summary of the data is presented herein and the remaining data are presented
in the appendices of this document.  In the tables, S indicates the bacteria were
susceptible to the antibiotic, MR indicates the bacteria were moderately resistant, and R
indicates the bacteria were resistant to the antibiotic.  In general, the bacteria in the plant
were resistant to the beta-lactam antibiotics, including penicillin, ampicillin, and
cephalothin.  Bacteria in the influent were more resistant to the antibiotics examined than
in the other flow streams.  Bacteria in the plant were usually resistant to bacitracin and
vancomycin.  The resistance to amoxicillin with clavulanic acid, streptomycin, rifampin,
and ciprofloxacin varied monthly.
The data showed that antibiotic resistance patterns changed in the plant, which
may be a consequence of the organisms present and the fluctuations of organism
population (Hassani et al., 1992; Imzilin et al., 1996).  Of particular interest to this study
was the resistance to the beta-lactam antibiotics.  The organisms were resistant to the
beta-lactam antibiotics.  Generally, bacteria grew completely up to the disk.  The
resistance observed in the LWRP complemented the results obtained from the JSC-WRS
and the TTU-WRS.  Both systems illustrated resistance to the beta-lactam antibiotics.
The addition of the beta-lactamase inhibitor, clavulanic acid, slightly reduced
(moderately resistant versus resistant) the organisms' resistance to the amoxicillin, as
compared to the resistance patterns of other beta-lactam antibiotics.
In addition, the bacteria exhibited different antibiotic resistant mechanisms.  Table
4 contained the antibiotic and the mechanism of disinfection. The results of this
experiment indicated the prevalence of antibiotic resistance in the LWRP and possible
health effects and concerns to the ecosystems and end users of the water containing
LWRP discharges.  The concern of antibiotic resistance transfer from bacteria in the
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effluent of the LWRP to bacteria in the surrounding environment is a concern, especially
if antibiotic resistance is spread to pathogenic bacteria.
Table 6.  Antibiotic Resistance in the Influent of the LWRP.
Antibiotic Jun Jul Aug Sept Oct Nov Dec
Amoxicillin with
clavulanic acid
R R R MR S S R
Ampicillin R R R R R R R
Bacitracin R R R NA R R R
Cephalothin R R R R R R R
Ciprofloxacin S R R S R S MR
Penicillin R R R R R R R
Rifampin R R MR MR R R R
Streptomycin MR R MR R S R R
Tetracycline NA R R R NA NA NA
Vancomycin R R R R R R R
Table 7.  Antibiotic Resistance in the Primary Sludge of the LWRP.
Antibiotic Jun Jul Aug Sept Oct Nov Dec
Amoxicillin with
clavulanic acid
MR S MR MR MR R R
Ampicillin R R R R R R R
Bacitracin R R R NA R R R
Cephalothin R R R R R R R
Ciprofloxacin MR S MR S MR MR S
Penicillin R R R R R R R
Rifampin R MR MR R R R MR
Streptomycin MR MR S R R R R
Tetracycline NA R MR R NA NA NA
Vancomycin R R R R R R R
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Table 8.  Antibiotic Resistance in the Activated Sludge of the LWRP.
Antibiotic Jun Jul Aug Sept Oct Nov Dec
Amoxicillin with
clavulanic acid
S R S MR S S S
Ampicillin R R S R R R R
Bacitracin R R R NA R R R
Cephalothin R R R R R R R
Ciprofloxacin S R S S R S MR
Penicillin R R R R R R R
Rifampin S MR MR S R R R
Streptomycin MR R S R S MR S
Tetracycline NA R S MR NA NA NA
Vancomycin R R R R R R R
Table 9.  Antibiotic Resistance in the Effluent of the LWRP.
Antibiotic Jun Jul Aug Sept Oct Nov Dec
Amoxicillin with
clavulanic acid
S S S R S S S
Ampicillin R R MR R S S S
Bacitracin R R R NA R R R
Cephalothin R R MR R MR MR R
Ciprofloxacin S R S R S S S
Penicillin R R R R MR R R
Rifampin MR MR S R R S MR
Streptomycin S S R R S S S
Tetracycline NA S S R NA NA NA
Vancomycin R R S R R R R
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In the LWRP, bacteria were resistant to multiple antibiotics.  The greatest concern
was that antibiotic resistant bacteria in the effluent of the LWRP may spread the genetic
information encoding antibiotic resistance to organisms in the environment of the LWRP
outfall.  As a consequence, changing the antibiotic resistance properties of the bacteria in
an ecosystem may disrupt the ecosystem, and the water may be a health hazard to end-
users.  For example, say a person uses the LWRP water to irrigate his/her farmland.
During a visit at the farm, the farmer cuts their hand and the reclaimed wastewater comes
into contact with the wound.  Bacteria present in the water may infect the cut and the
farmer may be hospitalized with a difficult infection to cure.  This scenario is possible
with the use of reclaimed wastewater.  One solution to the aforementioned situation is to
thoroughly disinfect the wastewater before releasing to the environment or the end users.
This will minimize the bacterial population in the wastewater and minimize the exposure
of the receiving ecosystem to antibiotic resistant bacteria.
Amoxicillin was detected in the influent of the LWRP on only one occasion
during the eight-month study.  Amoxicillin was not detected in the plant’s flow streams
(primary sludge, activated sludge or in the LWRP effluent).  Due to the dilution of toilet
flush water, 28 percent of interior residential water use (Metcalf and Eddy, 1991) with
other domestic and municipal water flow streams, the concentration of amoxicillin is
anticipated to be at or below the detection limit.  In addition, it is unlikely that everyone
served by the LWRP would be on antibiotics.  Higher concentrations of amoxicillin may
be observed in the effluent of a hospital or other medical facility; however, samples of
this nature were not collected in this research.  Based on the results of this study,
amoxicillin, when present, is be believed to be degraded in the microbially-active sewer
systems that transmit wastewater from the producers to the wastewater treatment plant.
Thus, it is unlikely that amoxicillin would be present in the influent of the LWRP at
concentrations greater than detected in this study.
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CONCLUSIONS AND RECOMMENDATIONS
A recent concern of reusing wastewater for consumption is the presence of
chemical contaminants, including a new category of compounds: personal care products
and pharmaceuticals.  Antibiotics are an especially troubling class of compounds due to
their ability to produce antibiotic resistance in bacterial populations.  Antibiotics enter the
environment from a variety of sources including discharges from domestic wastewater
treatment plants and pharmaceutical companies, runoff from animal feeding operations,
infiltration from aquaculture activities, leachate from landfills, and leachate from
compost made of animal manure containing antibiotics.  However, antibiotics are not
confined to the natural aquatic environment.  Detectable concentrations of antibiotics
have been observed in tap water (Herberer et al., 1998; Masters, 2001).  The startling fact
is that these compounds are passing through water treatment processes and contaminating
drinking water supplies.  The concentrations of these contaminants typically range from
nanogram/liter (ng/L) to microgram/liter (mg/L); the consequence of their presence at
these concentrations is unknown.  The overall potential for antibiotic removal by
biological and physiochemical treatment systems and simultaneous risk of antibiotic
resistance development has been relatively unexplored.  The objective of this research
was to investigate the effect of a representative pharmaceutical in a biological water
reclamation system.  The antibiotic evaluated in this study was amoxicillin, which is a
semi-synthetic, beta-lactam antibiotic used for a variety of infections. The objective of
this particular project is to determine the fate of amoxicillin in the City of Lubbock’s
Wastewater Reclamation Plant and determine the antibiotic resistance patterns in the
plant.
Amoxicillin was detected in the influent of the LWRP on only one occasion
during the eight-month study.  Amoxicillin was not detected in the plant’s flow streams
(primary sludge or activated sludge or in the LWRP effluent).  Due to the small
percentage of the cities population on amoxicillin at any given time and the ease at which
amoxicillin is degraded, it is unlikely that amoxicillin would be present in the influent of
the LWRP at concentrations greater than detected in this study.  In the LWRP, bacteria
were resistant to multiple antibiotics. Resistance to beta-lactam antibiotics was common,
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as indicated by the results of the and disk diffusion tests.  The beta-lactam antibiotics
investigated include penicillin, ampicillin, amoxicillin, and cephalothin.  For the disk
diffusion tests, amoxicillin was only available combined with the beta-lactamase
inhibitor, clavulanic acid.  In many cases, the beta-lactamase inhibitor was ineffective
and organisms in the systems investigated were resistant to the beta-lactam, beta-
lactamase inhibitor combination.  Thus, the bacteria in the LWRP had the genetic
mechanisms for beta-lactamase production, which provided resistance to beta-lactam
antibiotics and beta-lactamase inhibiting compounds (i.e., clavulanic acid), which may be
the consequence of overproduction of beta-lactamases or bacterial mutations in the
clavulanic acid target.
The greatest concern is that antibiotic resistant bacteria in the effluent of the
LWRP may spread the genetic information encoding antibiotic resistance to organisms in
the environment of the LWRP outfall.  As a consequence, changing the antibiotic
resistance properties of the bacteria in the ecosystem may disrupt the ecosystem and the
water may be a health hazard to end-users.  For example, a person uses the LWRP water
to irrigate their farmland.  During an irrigation event, the farmer cuts his/her hand and the
reclaimed wastewater comes into contact with the wound.  Bacteria present in the water
may infect the cut and the farmer may be hospitalized with a difficult infection to cure.
This is a scenario is possible with the use of reclaimed wastewater.
One solution to the aforementioned situation is to thoroughly disinfect the
wastewater before releasing to the environment or end-users.  This will minimize the
bacterial population in the wastewater and minimize the exposure of the receiving
ecosystem to antibiotic resistant bacteria. However, disinfection requirements may need
to become more stringent to protect the ecosystems downstream from the wastewater
treatment plant’s outfall.
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Table A.1.  LWRP Susceptibility test results for June.
INFLUENT       
Diameter of Disk (cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.2 0.7 1.0 1.0 0.3 Resistant
Ampicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Bacitracin 0.7 0.7 0.7 0.7 0.0 Resistant
Cephalothin 0.7 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 0.8 2.3 0.7 1.3 0.9 Susceptible
Rifampin 1.0 0.9 0.7 0.9 0.2 Resistant
Streptomycin 0.8 2.0 0.7 1.2 0.7 Mod. Resistant
Tetracycline NA NA NA NA NA NA
Vancomycin 0.8 0.7 0.7 0.7 0.1 Resistant
PRIMARY SLUDGE
Diameter of Disk (cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.3 1.1 1.0 1.1 0.2 Mod. Resistant
Ampicillin 0.7 0.9 0.7 0.8 0.1 Resistant
Bacitracin 0.7 0.7 0.7 0.7 0.0 Resistant
Cephalothin 0.7 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 1.0 1.0 1.2 1.1 0.1 Mod. Resistant
Rifampin 0.9 1.2 0.9 1.0 0.2 Resistant
Streptomycin 1.0 1.2 1.0 1.1 0.1 Mod. Resistant
Tetracycline NA NA NA NA NA NA
Vancomycin 0.7 0.7 0.9 0.8 0.1 Resistant
ACTIVATED SLUDGE
Diameter of Disk (cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 2.8 1.1 1.4 1.8 0.9 Susceptible
Ampicillin 0.7 0.7 1.0 0.8 0.2 Resistant
Bacitracin 0.8 1.0 0.8 0.9 0.1 Resistant
Cephalothin 0.7 0.8 0.7 0.7 0.1 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 1.6 1.0 1.7 1.4 0.4 Susceptible
Rifampin 1.2 2.1 1.4 1.6 0.5 Susceptible
Streptomycin 1.4 1.2 2.4 1.7 0.6 Susceptible
Tetracycline NA NA NA NA NA NA
Vancomycin 0.8 0.8 0.7 0.8 0.1 Resistant
EFFLUENT
Diameter of Disk (cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.8 2.4 1.4 1.9 0.5 Susceptible
Ampicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Bacitracin 0.7 0.7 1.1 0.8 0.2 Resistant
Cephalothin 0.7 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 2.1 1.9 1.9 2.0 0.1 Susceptible
Rifampin 1.2 1.2 1.1 1.2 0.1 Mod. Resistant
Streptomycin 1.9 2.2 2.2 2.1 0.2 Susceptible
Tetracycline NA NA NA NA NA NA
Vancomycin 0.8 0.8 0.9 0.8 0.1 Resistant
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Table A.2.  LWRP susceptibility test results for July.
INFLUENT       
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.2 0.9 1.0 1.0 0.2 Resistant
Ampicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Bacitracin 0.7 0.7 0.7 0.7 0.0 Resistant
Cephalothin 0.7 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 0.7 0.7 0.7 0.7 0.0 Resistant
Rifampin 0.8 1.0 1.1 1.0 0.2 Resistant
Streptomycin 0.7 0.9 0.9 0.8 0.1 Resistant
Tetracycline 0.8 0.8 1.0 0.9 0.1 Resistant
Vancomycin 0.7 0.7 0.7 0.7 0.0 Resistant
PRIMARY SLUDGE
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.1 1.7 1.4 1.4 0.3 Susceptible
Ampicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Bacitracin 0.7 0.8 0.9 0.8 0.1 Resistant
Cephalothin 0.7 1.0 0.7 0.8 0.2 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 1.0 1.4 1.5 1.3 0.3 Susceptible
Rifampin 1.1 1.2 1.2 1.2 0.1 Mod. Resistant
Streptomycin 0.9 1.2 1.3 1.1 0.2 Mod. Resistant
Tetracycline 0.8 1.1 1.0 1.0 0.2 Resistant
Vancomycin 0.9 0.9 0.8 0.9 0.1 Resistant
ACTIVATED SLUDGE
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 0.7 1.1 0.9 0.3 Resistant
Ampicillin 0.7 0.7 0.7 0.0 Resistant
Bacitracin 0.7 0.8 0.8 0.1 Resistant
Cephalothin 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.7 0.7 Resistant
Ciprofloxacin 0.7 0.7 0.8 0.7 0.1 Resistant
Rifampin 1.0 1.5 0.8 1.1 0.4 Mod. Resistant
Streptomycin 0.7 0.7 0.7 0.7 0.0 Resistant
Tetracycline 1.0 0.7 0.7 0.8 0.2 Resistant
Vancomycin 0.7 0.7 0.7 0.7 0.0 Resistant
EFFLUENT
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.8 1.8 1.6 1.7 0.1 Susceptible
Ampicillin 0.8 0.7 0.7 0.7 0.1 Resistant
Bacitracin 0.8 0.9 0.8 0.8 0.1 Resistant
Cephalothin 0.8 1.0 1.0 0.9 0.1 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 1.1 0.8 0.7 0.9 0.2 Resistant
Rifampin 1.2 1.4 1.0 1.2 0.2 Mod. Resistant
Streptomycin 1.6 1.4 8.0 3.7 3.8 Susceptible
Tetracycline 1.6 1.4 1.2 1.4 0.2 Susceptible
Vancomycin 0.8 1.0 0.8 0.9 0.1 Resistant
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Table A.3.  LWRP susceptibility test results for August.
INFLUENT       
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 0.7 0.8 1.0 0.8 0.2 Resistant
Ampicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Bacitracin 0.7 0.7 0.7 0.7 0.0 Resistant
Cephalothin 0.7 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 0.9 0.7 1.0 0.9 0.2 Resistant
Rifampin 1.1 0.7 1.4 1.1 0.4 Mod. Resistant
Streptomycin 1.4 1.1 1.1 1.2 0.2 Mod. Resistant
Tetracycline 0.8 1.0 1.0 0.9 0.1 Resistant
Vancomycin 0.7 0.7 0.8 0.7 0.1 Resistant
PRIMARY SLUDGE
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.1 1.0 1.3 1.1 0.2 Mod. Resistant
Ampicillin 0.8 0.7 0.7 0.7 0.1 Resistant
Bacitracin 0.7 0.7 0.7 0.7 0.0 Resistant
Cephalothin 0.7 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 1.2 1.1 1.1 1.1 0.1 Mod. Resistant
Rifampin 1.0 1.2 1.0 1.1 0.1 Mod. Resistant
Streptomycin 1.0 1.4 1.4 1.3 0.2 Susceptible
Tetracycline 1.2 1.0 1.2 1.1 0.1 Mod. Resistant
Vancomycin 0.7 0.7 0.7 0.7 0.0 Resistant
ACTIVATED SLUDGE
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.8 1.7 1.2 1.6 0.3 Susceptible
Ampicillin 1.0 1.2 1.6 1.3 0.3 Susceptible
Bacitracin 0.7 0.7 0.7 0.7 0.0 Resistant
Cephalothin 0.7 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 1.4 2.8 1.8 2.0 0.7 Susceptible
Rifampin 1.0 0.8 1.1 1.0 0.2 Mod. Resistant
Streptomycin 1.4 1.9 1.2 1.5 0.4 Susceptible
Tetracycline 1.0 1.6 1.8 1.5 0.4 Susceptible
Vancomycin 0.7 0.7 0.7 0.7 0.0 Resistant
EFFLUENT
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.2 2.2 2.4 1.9 0.6 Susceptible
Ampicillin 1.0 1.2 1.0 1.1 0.1 Mod. Resistant
Bacitracin 0.8 1.0 0.7 0.8 0.2 Resistant
Cephalothin 0.7 0.7 2.2 1.2 0.9 Mod. Resistant
Penicillin 0.7 0.7 1.2 0.9 0.3 Resistant
Ciprofloxacin 1.0 2.0 2.4 1.8 0.7 Susceptible
Rifampin 1.8 1.6 2.2 1.9 0.3 Susceptible
Streptomycin 1.1 0.8 0.7 0.9 0.2 Resistant
Tetracycline 3.8 4.0 3.8 3.9 0.1 Susceptible
Vancomycin 1.2 1.0 1.8 1.3 0.4 Susceptible
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Table A.4.  LWRP susceptibility test results for September.
INFLUENT       
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.0 1.1 1.4 1.2 0.2 Mod. Resistant
Ampicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Bacitracin - - - - - -
Cephalothin 0.7 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 1.3 1.4 1.2 1.3 0.1 Susceptible
Rifampin - - 1.1 1.1 - Mod. Resistant
Streptomycin - 0.8 - 0.8 - Resistant
Tetracycline 0.8 1.1 0.9 0.9 0.2 Resistant
Vancomycin 0.7 - - 0.7 - Resistant
PRIMARY SLUDGE
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.2 1.2 1.2 1.2 0.0 Mod. Resistant
Ampicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Bacitracin - - - - - -
Cephalothin 0.7 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 1.3 1.4 1.2 1.3 0.1 Susceptible
Rifampin 1.0 - - 1.0 - Resistant
Streptomycin - 1.0 - 1.0 - Resistant
Tetracycline 1.0 1.0 1.0 1.0 0.0 Resistant
Vancomycin - - 0.7 0.7 - Resistant
ACTIVATED SLUDGE
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 0.9 1.3 1.2 1.1 0.2
Moderately
Resistant
Ampicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Bacitracin - - - - - -
Cephalothin 0.7 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 1.1 1.6 1.6 1.4 0.3 Susceptible
Rifampin 1.5 - - 1.5 - Susceptible
Streptomycin - 0.8 - 0.8 - Resistant
Tetracycline 1.1 1.1 1.0 1.1 0.1 Mod. Resistant
Vancomycin - - 0.7 0.7 - Resistant
EFFLUENT
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.3 0.8 1.0 1.0 0.3 Resistant
Ampicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Bacitracin - - - - - -
Cephalothin 0.7 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 0.7 0.8 0.8 0.8 0.1 Resistant
Rifampin 1.0 - - 1.0 - Resistant
Streptomycin 1.1 0.7 - 0.9 0.3 Resistant
Tetracycline 0.7 0.7 0.8 0.7 0.1 Resistant
Vancomycin 0.7 - 0.7 0.7 0.0 Resistant
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Table A.5.  LWRP susceptibility test results for October.
INFLUENT       
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.2 1.5 1.4 1.4 - Susceptible
Ampicillin 0.7 0.7 - 0.7 - Resistant
Bacitracin 0.7 0.7 - 0.7 - Resistant
Cephalothin 0.9 0.7 - 0.8 - Resistant
Penicillin 0.7 0.7 - 0.7 - Resistant
Ciprofloxacin 0.7 0.7 - 0.7 - Resistant
Rifampin 0.8 0.8 - 0.8 - Resistant
Streptomycin 1.9 1.0 - 1.5 - Susceptible
Tetracycline - - - - - -
Vancomycin 0.7 0.7 - 0.7 - Resistant
PRIMARY SLUDGE
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 0.9 1.2 - 1.1 - Mod. Resistant
Ampicillin 0.7 0.7 - 0.7 - Resistant
Bacitracin 0.7 0.7 - 0.7 - Resistant
Cephalothin 0.7 0.7 - 0.7 - Resistant
Penicillin 0.7 0.7 - 0.7 - Resistant
Ciprofloxacin 1.4 0.9 - 1.2 - Mod. Resistant
Rifampin 0.7 0.7 - 0.7 - Resistant
Streptomycin 0.7 0.7 - 0.7 - Resistant
Tetracycline - - - - - -
Vancomycin 0.7 0.7 - 0.7 - Resistant
ACTIVATED SLUDGE
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.6 1.6 - 1.6 - Susceptible
Ampicillin 0.7 0.7 - 0.7 - Resistant
Bacitracin 0.7 0.7 - - - Resistant
Cephalothin 0.7 0.7 - 0.7 - Resistant
Penicillin 0.7 0.7 - 0.7 - Resistant
Ciprofloxacin 0.9 0.7 - 0.8 - Resistant
Rifampin 0.7 0.7 - 0.7 - Resistant
Streptomycin 0.8 1.7 - 1.3 - Susceptible
Tetracycline - - - - - -
Vancomycin 0.7 0.7 - 0.7 - Resistant
EFFLUENT
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.8 2.2 - 2.0 - Susceptible
Ampicillin 1.2 1.4 - 1.3 - Susceptible
Bacitracin 0.7 0.8 - 0.8 - Resistant
Cephalothin 1.2 1.2 - 1.2 - Mod. Resistant
Penicillin 1.2 0.9 - 1.1 - Mod. Resistant
Ciprofloxacin 2.0 1.2 - 1.6 - Susceptible
Rifampin 1.0 - - 1.0 - Resistant
Streptomycin 2.0 1.6 - 1.8 - Susceptible
Tetracycline - - - - - -
Vancomycin 0.7 0.7 - 0.7 - Resistant
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Table A.6.  LWRP susceptibility test results for November.
INFLUENT       
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 0.7 1.9 2.0 1.5 0.7 Susceptible
Ampicillin 1.1 1.2 0.7 1.0 0.3 Resistant
Bacitracin 0.7 0.7 - 0.7 - Resistant
Cephalothin 0.7 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.8 0.8 0.7 0.8 0.1 Resistant
Ciprofloxacin 2.0 1.5 1.6 1.7 0.3 Susceptible
Rifampin 0.7 0.7 - 0.7 - Resistant
Streptomycin 0.7 0.8 - 0.8 - Resistant
Tetracycline - - - - - -
Vancomycin 0.7 - - 0.7 - Resistant
PRIMARY SLUDGE
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.1 0.8 0.8 0.9 0.2 Resistant
Ampicillin 0.7 0.7 0.8 0.7 0.1 Resistant
Bacitracin 0.7 0.7 - 0.7 - Resistant
Cephalothin 0.7 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 1.0 1.0 1.5 1.2 0.3 Mod. Resistant
Rifampin 0.8 0.8 - 0.8 - Resistant
Streptomycin 1.0 0.7 - 0.9 - Resistant
Tetracycline - - - - - -
Vancomycin 0.7 0.7 - 0.7 - Resistant
ACTIVATED SLUDGE
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.6 1.6 2.0 1.7 0.2 Susceptible
Ampicillin 1.2 0.7 0.8 0.9 0.3 Resistant
Bacitracin 0.7 0.7 - 0.7 - Resistant
Cephalothin 0.7 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 1.4 2.0 1.2 1.5 0.4 Susceptible
Rifampin 0.7 1.0 - 0.9 - Resistant
Streptomycin 0.7 1.4 - 1.1 - Mod. Resistant
Tetracycline - - - - - -
Vancomycin 0.7 0.7 - 0.7 - Resistant
EFFLUENT
Diameter of Disk
(cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 2.0 2.2 1.1 1.8 0.6 Susceptible
Ampicillin 1.5 1.3 2.4 1.7 0.6 Susceptible
Bacitracin 0.7 0.7 - 0.7 - Resistant
Cephalothin 0.7 1.0 1.6 1.1 0.5 Mod. Resistant
Penicillin 0.7 1.2 0.7 0.9 0.3 Resistant
Ciprofloxacin 2.4 1.4 2.2 2.0 0.5 Susceptible
Rifampin 1.7 0.9 - 1.3 - Susceptible
Streptomycin 1.6 0.9 - 1.3 - Susceptible
Tetracycline - - - - - -
Vancomycin 0.7 0.7 - 0.7 - Resistant
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Table A.7.  LWRP susceptibility test results for December.
INFLUENT       
Diameter of Disk (cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 0.9 0.9 0.9 0.9 0.0 Resistant
Ampicillin 0.7 0.7 0.8 0.7 0.1 Resistant
Bacitracin 0.7 0.7 0.7 0.7 0.0 Resistant
Cephalothin 0.8 0.7 0.7 0.7 0.1 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 1.2 1.1 1.0 1.1 0.1 Mod. Resistant
Rifampin 0.7 0.7 0.8 0.7 0.1 Resistant
Streptomycin 0.7 0.7 0.8 0.7 0.1 Resistant
Tetracycline - - - - - -
Vancomycin 0.7 0.7 0.7 0.7 0.0 Resistant
PRIMARY SLUDGE
Diameter of Disk (cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 0.9 1.0 1.0 1.0 0.1 Resistant
Ampicillin 0.7 0.8 0.8 0.8 0.1 Resistant
Bacitracin 0.7 0.7 - 0.7 - Resistant
Cephalothin 0.7 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.7 0.7 0.7 0.7 0.0 Resistant
Ciprofloxacin 1.5 1.5 1.1 1.4 0.2 Susceptible
Rifampin 1.1 1.1 - 1.1 - Mod. Resistant
Streptomycin 0.8 0.8 - 0.8 - Resistant
Tetracycline - - - - - -
Vancomycin 0.7 0.7 - 0.7 - Resistant
ACTIVATED SLUDGE
Diameter of Disk (cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 1.0 1.6 1.4 1.3 0.3 Susceptible
Ampicillin 0.8 0.7 0.7 0.7 0.1 Resistant
Bacitracin 0.8 0.8 - 0.8 - Resistant
Cephalothin 0.7 0.7 0.7 0.7 0.0 Resistant
Penicillin 0.7 0.7 0.8 0.7 0.1 Resistant
Ciprofloxacin 1.2 1.2 1.2 1.2 0.0 Mod. Resistant
Rifampin 0.9 0.8 - 0.9 - Resistant
Streptomycin 1.6 1.1 - 1.4 - Susceptible
Tetracycline - - - - - -
Vancomycin 0.7 0.7 - 0.7 - Resistant
EFFLUENT
Diameter of Disk (cm) Average Stnd Dev Results
Amoxicillin w/ clav.acid 2.8 2.0 1.0 1.9 0.9 Susceptible
Ampicillin 1.0 1.4 2.0 1.5 0.5 Susceptible
Bacitracin 0.7 1.0 1.6 1.1 0.5 Resistant
Cephalothin 1.4 0.9 0.7 1.0 0.4 Resistant
Penicillin 2.0 1.0 0.7 1.2 0.7 Resistant
Ciprofloxacin 2.0 1.6 2.2 1.9 0.3 Susceptible
Rifampin 1.5 1.2 0.7 1.1 - Mod. Resistant
Streptomycin 3.1 1.8 2.0 2.3 - Susceptible
Tetracycline - - - - - -
Vancomycin 0.7 1.0 0.9 0.9 - Resistant
